Significant biomarkers for the management of hepatocellular carcinoma.

about

Imaging of HCC-Current State of the Art Recent advances in hepatocellular carcinoma therapy.Significance of PIVKA-II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus-associated hepatocellular carcinoma.

P2860

Q26768463-C5C2AE97-DA36-4B38-B3FD-44CDA8422569 Q30236010-C221CD09-DB15-4331-B13B-BC6971FDCF4A Q55333212-D021FF0F-15F8-4F08-BFCB-15AED113011E

P2860

Significant biomarkers for the management of hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q38412315

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Significant biomarkers for the management of hepatocellular carcinoma.

@en

type

Item

label

Significant biomarkers for the management of hepatocellular carcinoma.

@en

prefLabel

Significant biomarkers for the management of hepatocellular carcinoma.

@en

P1476

Significant biomarkers for the management of hepatocellular carcinoma.

@en

P2093

Osamu Kimura

http://www.w3.org/2001/XMLSchema#string

Tooru Shimosegawa

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Global cancer statistics, 2002

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

The global health burden of infection-associated cancers in the year 2002

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

HCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases.

Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B

Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

P2888

s12328-015-0568-9

P304

109-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12328-015-0568-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yasuteru Kondo

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274725902

http://www.w3.org/2001/XMLSchema#string

P6179

1053696341

http://www.w3.org/2001/XMLSchema#string

P698

25855582

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Significant biomarkers for the management of hepatocellular carcinoma.

about

P2860

P2860

Significant biomarkers for the management of hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921